These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 25534278

  • 1. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J, Maclean J, Nyiri B, Li Y, Malone K, Avruch L, Kayser C, Malone S.
    Radiat Oncol; 2014 Dec 23; 9():303. PubMed ID: 25534278
    [Abstract] [Full Text] [Related]

  • 2. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S, Croke J, Roustan-Delatour N, Belanger E, Avruch L, Malone C, Morash C, Kayser C, Underhill K, Li Y, Malone K, Nyiri B, Spaans J.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):725-32. PubMed ID: 22444999
    [Abstract] [Full Text] [Related]

  • 3. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G, Castellone P, Foppiano F, Franzone P, Marcenaro M, Tognoni P, Bolognesi A, Ceresoli GL, Fiorino C.
    Strahlenther Onkol; 2004 Sep 01; 180(9):563-72. PubMed ID: 15378187
    [Abstract] [Full Text] [Related]

  • 4. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J, Paluska, Odrázka K, Belobradek Z, Hoffmann P, Prosvic P, Brod'ák M, Louda M, Macingová Z, Vosmik M.
    Klin Onkol; 2010 Sep 01; 23(4):256-63. PubMed ID: 20806824
    [Abstract] [Full Text] [Related]

  • 5. Local recurrence map to guide target volume delineation after radical prostatectomy.
    Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA.
    Pract Radiat Oncol; 2014 Sep 01; 4(6):e239-46. PubMed ID: 25407875
    [Abstract] [Full Text] [Related]

  • 6. Postoperative radiotherapy in prostate cancer: the case of the missing target.
    Croke J, Malone S, Roustan Delatour N, Belanger E, Avruch L, Morash C, Kayser C, Underhill K, Spaans J.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1160-8. PubMed ID: 22270169
    [Abstract] [Full Text] [Related]

  • 7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1897-902. PubMed ID: 21536391
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients.
    Diot Q, Olsen C, Kavanagh B, Raben D, Miften M.
    Med Phys; 2010 Feb 01; 37(2):629-37. PubMed ID: 20229872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S, Chan G, Craig T, Weinberg V, Cheng C, Roach M, Cheung P, Sahgal A.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):e657-62. PubMed ID: 22245189
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, Prosvic P, Macingova Z, Vosmik M, Hoffmann P, Louda M, Nejedla A.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):911-8. PubMed ID: 21420244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
    Su A, Blend MJ, Spelbring D, Hamilton RJ, Jani AB.
    Clin Nucl Med; 2006 Mar 01; 31(3):139-44. PubMed ID: 16495731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer.
    Sawayanagi S, Yamashita H, Ogita M, Kiritoshi T, Nakamoto T, Abe O, Nakagawa K.
    Radiat Oncol; 2018 Apr 17; 13(1):70. PubMed ID: 29665832
    [Abstract] [Full Text] [Related]

  • 18. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
    Harris VA, Staffurth J, Naismith O, Esmail A, Gulliford S, Khoo V, Lewis R, Littler J, McNair H, Sadoyze A, Scrase C, Sohaib A, Syndikus I, Zarkar A, Hall E, Dearnaley D, PIVOTAL Trialists.
    Int J Radiat Oncol Biol Phys; 2015 Jul 15; 92(4):874-83. PubMed ID: 26104940
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I, Dirkx ML, Heijmen BJ.
    Radiother Oncol; 2009 Jul 15; 92(1):62-7. PubMed ID: 19278745
    [Abstract] [Full Text] [Related]

  • 20. Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy).
    Pinkawa M, Siluschek J, Gagel B, Piroth MD, Demirel C, Asadpour B, Eble MJ.
    Strahlenther Onkol; 2007 Jan 15; 183(1):23-9. PubMed ID: 17225942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.